Back to Search Start Over

Quality assessment of Rheum species cultivated in Japan by focusing on M2 polarization of microglia.

Authors :
Kuboyama T
Hotta K
Asanuma M
Ge YW
Toume K
Yamazaki T
Komatsu K
Source :
Journal of natural medicines [J Nat Med] 2023 Sep; Vol. 77 (4), pp. 699-711. Date of Electronic Publication: 2023 Jun 22.
Publication Year :
2023

Abstract

In traditional Japanese medicine, Rhei Rhizoma is used as a purgative, blood stasis-resolving and antipsychotic drug. The latter two properties are possibly related to anti-inflammatory effects. Microglia regulate inflammation in the central nervous system. M1 microglia induce inflammation, while M2 microglia inhibit inflammation and show neurotrophic effects. This study investigated the effects from water extracts of roots of cultivated Rheum species in Nagano Prefecture, Japan (strain C, a related strain to a Japanese cultivar, 'Shinshu-Daio'; and strain 29, a Chinese strain) and 3 kinds of Rhei Rhizoma available in the Japanese market, and also examined their constituents on the polarization of cultured microglia. All extracts significantly decreased M1 microglia, and strains C and 29 significantly increased M2 microglia. Furthermore, the extracts of both strains significantly increased the M2/M1 ratio. Among the constituents of Rhei Rhizoma, ( +)-catechin (2), resveratrol 4'-O-β-D-(6″-O-galloyl) glucopyranoside (5), isolindleyin (8), and physcion (15) significantly increased the M2/M1 ratio. The contents of the constituents in water extract of each strain were quantified using HPLC. The extracts of strains C and 29 contained relatively large amounts of 2 and 5; and 2, 8, and 15, respectively. This study showed the water extracts of roots of cultivated Rheum strains in Japan had the effects of M2 polarization of microglia, suggesting that these strains become the candidate to develop anti-inflammatory Rhei Rhizoma. Moreover, the suitable chemical composition to possess anti-inflammatory activity in the brain was clarified for the future development of new type of Rhei Rhizoma.<br /> (© 2023. The Author(s) under exclusive licence to The Japanese Society of Pharmacognosy.)

Details

Language :
English
ISSN :
1861-0293
Volume :
77
Issue :
4
Database :
MEDLINE
Journal :
Journal of natural medicines
Publication Type :
Academic Journal
Accession number :
37347410
Full Text :
https://doi.org/10.1007/s11418-023-01710-0